Trials / Conditions / Stage IV Major Salivary Gland Cancer AJCC v8
Stage IV Major Salivary Gland Cancer AJCC v8
5 registered clinical trials studyying Stage IV Major Salivary Gland Cancer AJCC v8 — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus NCT05408845 | NRG Oncology | Phase 2 |
| Active Not Recruiting | Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Tr NCT04576091 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tu NCT04704661 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer NCT04895735 | Mayo Clinic | Phase 2 |
| Completed | Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Canc NCT03749460 | University of Washington | Phase 1 / Phase 2 |